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Abstract
Background: Francisella tularensis subsp. tularensis is classified as a Category A bioweapon that is
capable of establishing a lethal infection in humans upon inhalation of very few organisms. However,
the virulence mechanisms of this organism are not well characterized. Francisella tularensis subsp.
novicida, which is an equally virulent subspecies in mice, was used in concert with a microPET
scanner to better understand its temporal dissemination in vivo upon intranasal infection and how
such dissemination compares with other routes of infection. Adult mice were inoculated
intranasally with F. tularensis subsp. novicida radiolabeled with 64Cu and imaged by microPET at 0.25,
2 and 20 hours post-infection.
Results: 64Cu labeled F. tularensis subsp. novicida administered intranasally or intratracheally were
visualized in the respiratory tract and stomach at 0.25 hours post infection. By 20 hours, there was
significant tropism to the lung compared with other tissues. In contrast, the images of radiolabeled
F. tularensis subsp. novicida when administered intragastrically, intradermally, intraperitoneally and
intravenouslly were more generally limited to the gastrointestinal system, site of inoculation, liver
and spleen respectively. MicroPET images correlated with the biodistribution of isotope and
bacterial burdens in analyzed tissues.
Conclusion: Our findings suggest that Francisella has a differential tissue tropism depending on
the route of entry and that the virulence of Francisella by the pulmonary route is associated with
a rapid bacteremia and an early preferential tropism to the lung. In addition, the use of the
microPET device allowed us to identify the cecum as a novel site of colonization of Francisella
tularensis subsp. novicida in mice.
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Background
Francisella tularensis is a facultative intracellular pathogen
that is the causative agent of tularemia. Francisella has a
broad host range as it is able to infect amoeba, arthro-
pods, rodents and higher mammalian species [1-4]. The
primary replication site in humans appears to be the mac-
rophage although other cell types have been implicated
[5-7]. Infection is established through contact with
infected tissues, arthropod bites, inhalation or ingestion
which can lead to various clinical manifestations [3,8].
The route of infection is a key determining factor in the
pathogenesis of this organism, and inhalation is the most
dangerous [3,9,10]. There are two subspecies of F. tularen-
sis, that are capable of causing disease in humans [9,10].
F. tularensis (type A) is primarily found in North America.
It is the most virulent strain and is capable of causing dis-
ease with as few as 10 organisms. The highly virulent
nature of this microorganism combined with its ability to
be aerosolized has led to its designation as a Category A
biological warfare agent by the CDC [3,11]. F. tularensis
subsp. holarctica (type B) is less virulent than type A, but it
is found more readily across the northern hemisphere.
Type B is also the parent strain from which the important
F. tularensis LVS was derived [12]. F. tularensis subsp. novi-
cida is another important laboratory strain as it remains
highly virulent in mice but can be studied in a BSL-2 facil-
ity allowing access to new technology such as positron
emission tomography (PET).
PET has been utilized to detect cells, proteins and gene
expression in humans in vivo [13-15]. In humans, PET has
been used as a research tool for whole body imaging and
MicroPET imaging of bacterial infection of mice Figure 1
MicroPET imaging of bacterial infection of mice. Two-dimensional images of representative mice (ventral view) are 
depicted in the figure. MicroPET images were recorded over time from mice infected with either 64Cu labeled F. tularensis 
subsp. novicida, 64Cu labeled K. pneumoniae or 64Cu labeled E. coli. Mice were infected i.n, i.t, i.g, i.p, i.v and i.d with F. tularensis 
subsp. novicida (2 × 109 CFU/20 μl) and i.n with K. pneumoniae and E. coli using the same infection dose. Images were obtained 
at 0.25 hrs, 2 hrs and 20 hrs p.i. The red punctuated line represents the liver. The color scale on the right hand side of the fig-
ure is a linear scale that indicates percentage with red indicating 100% of signal and purple 0–10% or the lowest amount 
detected by imaging. Abbreviations: N: Nasal cavity, T: Trachea, L: Lung, GI: Gastrointestinal Tract, Li: Liver, S: Spleen, Le: Leg, 
Ce: Cecum.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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is now transitioning into diagnostic tools in oncology and
in the detection of Alzheimer's disease [16]. Recent
advances in microPET design have led to the production
of scanners that are capable of imaging rodents with high
resolution [13,17,18]. Advancements in labeling tech-
niques as well as different substrates [19,20] have allowed
for cell trafficking and distribution studies [15,21,22] as
well as for tracing bacteria in infections [23,24] and for
tumor detection [25]. The major advantage to utilizing
microPET imaging is that it is a non-invasive process with
high sensitivity that allows the investigator to perform
longitudinal studies on one animal rather than sacrificing
several animals at various time points [16].
We have exploited the capability of small animal micro-
PET coupled with radionuclide labeling to help us inves-
tigate the spatial and temporal biodistribution of F.
tularensis subsp. novicida in vivo. Mice were infected with
64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone)
([64Cu] PTSM) labeled F. tularensis subsp. novicida by dif-
ferent inoculation routes including intranasal, intratra-
cheal, intragastric, intraperitoneal, intravenous and
intradermal. The trafficking of labeled F. tularensis subsp.
novicida was compared with the control organisms E. coli
and K. pneumoniae using both microPET analysis and radi-
onuclide biodistribution analyses. Our results indicate
that F. tularensis subsp. novicida has a differential tissue
Biodistribution of 64Cu labeled F. tularensis subsp. novicida Figure 2
Biodistribution of 64Cu labeled F. tularensis subsp. novicida. In order to confirm the observations from the microPET 
images the distribution of labeled bacteria was further analyzed by measuring the amount of radioactivity present in individual 
tissues at 20 hrs p.i. The data represent an average of 3–9 mice per route of infection and are expressed as % ID/g of tissue. 
The data obtained for each of the tissues sampled following i.n infection was compared statistically to the same tissue when 
inoculated by the i.g, i.p and i.v routes by using a two tail Student's t-test [e.g. lung (i.n) to lung (i.g)]. * = p < 0.05, ** = p < 0.01 
and *** = p < 0.005. Data obtained following the i.d route was not included for the statistical analyses because it corresponded 
to just two biological replicates. The break in the scale was done between 110 and 120.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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tropism depending on the route of entry and that when
given by the intranasal or intratracheal route has a pro-
pensity to colonize the respiratory tract rapidly after infec-
tion tending to disseminate to other target organs within
a very short period of time.
Results
In vivo trafficking of bacteria in real time
F. tularensis subsp.  novicida, a highly virulent strain in
mice, was directly labeled with 64Cu-PTSM so that its
route of dissemination and anatomical distribution after
inoculation could be traced by repetitive microPET imag-
ing of live animals. C57BL/6 mice were infected i.n with 2
× 109 CFU/20–25 μl of bacteria and accumulated positron
emission measured for a 15 min period immediately after
inoculation (labeled 0.25 hr), 2 hrs and 20 hrs post-infec-
tion (p.i) by using a microPET scanner. Still images are
shown in Fig. 1, and images that can be rotated 360° can
be found in Additional File 1. Surprisingly, by 0.25 hr (15
min) p.i we observed radiolabel not only in the nasal cav-
ity at the site of inoculation but also in the lung and even
in the digestive tract (Fig. 1). The inoculum volume of 20–
25 μl has been shown to avoid introduction into the lung
[26,27], but the rapid spread was found repeatedly in
multiple animals. At 2 hrs p.i labeled organisms tracked to
the same organs but the amount of 64Cu detected by the
microPET increased in the lungs as well as the GI tract sug-
gesting an increase in the number of bacteria present in
these organs. Interestingly, the cecum was usually a hot
spot for labeled organisms. The images obtained 20 hrs
post-infection indicated a decrease in label intensity
present in the nasal cavity, an additional increase in the
lung and further spread through the GI tract (Fig. 1). The
recent acquisition of a FLEX Pre-Clinical Platform allowed
Biodistribution of viable vs. non viable 35S labeled bacteria Figure 3
Biodistribution of viable vs. non viable 35S labeled bacteria. As a mode to compare the localization of labeled bacteria, 
metabolic labeling was performed for F. tularensis subsp. novicida. The data represent an average of 3 mice per treatment and 
are expressed as cpm/g. Viable (unfixed) labeled F. tularensis subsp. novicida is found mainly in the lungs while there was an 
increase in non-viable (fixed) organisms localizing primarily to the gall bladder.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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us to obtain an X-ray computed tomography (CT) image
of the skeletal structure of mice that had been previously
infected by the i.p and i.v routes prior to acquire the
microPET images (Additional Files 2 and 3). The advan-
tage is that a fused image of the skeletal structure with the
microPET image is obtained and in this way a better indi-
cation of the localization of the labeled organisms in vivo
is possible. Additional Files 1, 2 and 3 show fused images
obtained at 0.25 hrs for i.n. i.p and i.v inoculations. To
further analyze isotope distribution, inoculated animals
were sacrificed, and several organs harvested to measure
the amount of radioisotope using an automatic well-type
γ counter. The combined ex-vivo data obtained from sev-
eral experiments are expressed as % input dose/g of tissue
(%ID/g) (Fig. 2). The results obtained with F. tularensis
subsp.  novicida  i.n infected animals correlate with the
microPET analyses indicating the highest concentration of
64Cu in the lung, stomach and GI tract. Importantly,
essentially all organs and tissues tested contained radioac-
tivity suggesting widespread dissemination of Francisella
by 20 hrs p.i.
To ensure that the radioactivity was indeed a measure of
viable labeled bacteria, four tissues were analyzed for
CFU/g of tissue at 20 hrs p.i (Additional File 6). Due to
normal flora, intestinal tissues were not analyzed but
Francisella is also known to colonize the liver. Consistent
with radioisotope measurements in vivo and ex vivo, the
lungs contained the highest bacterial burden with greater
than 4–5 logs of bacteria/g of tissue compared with the
bladder. The liver was also several logs lower reflective of
a %ID/g that was visualized by microPET at 20 hrs with a
blue/purple color indicative of lower levels of radioiso-
tope/g. Taken together; these results indicate that levels of
radioisotope reflect numbers of viable organisms. Because
of the rapidity of dissemination, the presence of viable
organisms in the blood was also tested and found to be
present (Additional File 6).
Viable vs. non-viable bacteria
To determine the effect of viability on bacterial trafficking,
F. tularensis subsp. novicida metabolically labeled with 35S-
L-methionine and 35S-L-cysteine was taken to a titer of 2 ×
Presence of F. tularensis subsp. novicida in the GI tract at early time points Figure 4
Presence of F. tularensis subsp. novicida in the GI tract at early time points. As a way to discard the possibility of 
swallowing of the inoculum during i.n and i.t infections we tested an endotracheal entubation of mice to directly deliver 35S 
labeled F. tularensis subsp. novicida into the trachea. Data shown represent an average of 3–4 mice and is given as cpm/g. Our 
biodistribution results showed that after 2 hrs p.i the majority of the labeled organisms were present in the lung and trachea; 
furthermore, a high proportion of labeled organisms were present in the stomach. In addition, after 20 hrs p.i the highest 
amount of labeled bacteria was present in the lung and further disseminated to other tissues including the cecum.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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109  and then fixed in 4% paraformaldehyde. Subse-
quently labeled bacteria were administered to mice i.n,
and the accumulation of label in various tissues was com-
pared with that of non-fixed, viable organisms. The data
are expressed as counts per minute/g (cpm/g) (Fig. 3) and
indicate that the bulk of the label was present in the lungs
at 20 hrs p.i when viable (unfixed) organisms were used
but more evenly distributed among the tissues analyzed
when non-viable (fixed) organisms were used. In addi-
tion, use of non-viable organisms resulted in a significant
increase in label in the gall bladder compared with viable
organisms.
Several of the tissues from mice receiving viable organ-
isms were also tested for CFU/g of tissue (data not
shown). Similar to the results obtained with 64Cu labe-
ling, the lung exhibited the highest bacterial burden from
all the organs tested. Viable bacteria were also detected in
the liver, spleen, superficial lymph nodes, Peyer's patches,
and blood correlating with the presence of isotope but at
lower levels in all of these tissues.
Effect of bacterial route of entry
Francisella tularensis can establish infection in the host
when entering through different routes. The severity of the
disease differs according to the route of infection and the
inhalation route is known to be the most dangerous form.
Due to these facts and to the results obtained in our
microPET studies following i.n infection, our laboratory
decided to study F. tularensis subsp. novicida in vivo distri-
bution following other routes of infection by which Fran-
cisella is also known to enter the host and cause disease.
First, we included an important control for the i.n infec-
tion. When bacteria were administered i.n in just 20–25
μl, labeled organisms appeared in the GI tract by 0.25 hr
(15 min) including the stomach, therefore it was impor-
tant to control for swallowing. So in a set of experiments,
mice were inoculated with the same dose of organisms (2
× 109 CFU) but by the i.t route (Fig. 1 and Additional File
4 left). The i.t inoculation was done by administering the
bacterial dose at the back of the throat while holding the
tongue in an extended position thus preventing swallow-
ing as described previously [28,29]. This explains label in
Biodistribution of 64Cu labeled bacteria Figure 5
Biodistribution of 64Cu labeled bacteria. The distribution of 64Cu labeled F. tularensis subsp. novicida was compared to 
64Cu labeled K. pneumoniae, 64Cu labeled E. coli and 64Cu labeled LVS in each tissue at 20 hrs pi. The data represent an average 
of 3 – 9 mice per infection and are given as %ID/g of tissue. The data obtained for each of the tissues sampled 20 hrs p.i from 
mice infected with F. tularensis subsp. novicida was compared statistically to the same tissue when inoculated with 64Cu labeled 
K. pneumoniae and E. coli at 20 hrs p.i by using a two tail Student's t-test [e.g. lung (i.n) to lung (i.g)]. * = p < 0.05, ** = p < 0.01 
and *** = p < 0.005.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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the head area at the site of inoculation. The results
obtained were similar in that labeled organisms could be
observed by microPET in the gastrointestinal tract by 0.25
hr (15 min). Similar to the i.n route, by 20 hrs the major-
ity of label appeared in the lung and GI tract including the
cecum although the relative amount of label in the lung
was higher, especially at 0.25 and 2 hrs p.i. The results
observed by microPET were confirmed by determining the
biodistribution of label ex vivo in various tissues and the
data represent an average of 3 animals after imaging (Fig.
2). To further discard the possibility of swallowing of the
inoculum during i.n and i.t infections we decided to test
an endotreacheal intubation of the mice to directly deliver
35S labeled F. tularensis subsp. novicida into the trachea.
Our biodistribution data shows that after 2 hrs p.i the
majority of the labeled bacteria are localized in the trachea
and lung; interestingly, there is also a high proportion of
labeled F. tularensis subsp. novicida present in the stomach
(Fig. 4). In addition, after 20 hrs p.i the biodistribution
data shows that the highest concentration of labeled bac-
teria appeared to be present in the lung and trachea fol-
lowed by the spleen; furthermore, labeled F. tularensis
subsp. novicida appeared to be present in the cecum as
well (Fig. 4). These results correlate with the ones
obtained by microPET, early after infection F. tularensis
subsp. novicida localizes in the lung and stomach, while
after 20 hrs p.i the bacterium remains in the lung and fur-
ther disseminates to other tissues including the cecum.
Also of relevance, F. tularensis is known to cause illness in
humans by ingestion, through cuts in the skin, as well as
systemically but with usually different clinical outcomes.
Therefore, mice were also inoculated with the same dose
of bacteria by the i.g, i.d, i.p and i.v routes. Following i.g
administration, the majority of labeled organisms
appeared in the GI tract and remained so for 20 hrs p.i
(Fig. 1 and Additional File 4 right). Substantial tropism to
the lung was not evident by 20 hrs. Mice inoculated by the
i.d route exhibited a different pattern (Fig. 1 and Addi-
tional File 5 right and left). The vast majority of the bacte-
ria injected appeared to remain at the site of inoculation
for the initial hours of infection. Consistent with this, the
distribution of label in isolated tissues indicated that the
vast majority of the label was localized to the skin and
muscle at 20 hrs (Fig. 2). Nonetheless, the isotope distri-
bution still suggested that there were bacteria in the blood
and several other tissues by 20 hrs although there was no
preferential tropism to the lung at this early time point. In
the case of mice infected by the i.p route, most of the
labeled bacterium 20 hrs after infection appeared to be
present in the liver as seen by microPET images with red-
yellow color indicating the high concentration of bacteria
in this tissue (Fig. 1), followed by the spleen and GI tract.
In addition, our observations indicated that there was not
a considerable amount of labeled bacteria present in the
Colonization of various tissues by F. tularensis subsp. novicida Figure 6
Colonization of various tissues by F. tularensis subsp. 
novicida. In order to determine the presence of F. tularensis 
subsp. novicida in the GI tract after i.n infection a Rif+ resist-
ant strain was generated. Data represent an average of 3 
mice per time point and are given as Log CFU/g of tissue. 
Lung, stomach, cecum, small intestine and large intestine 
were harvested at 2 hrs, 6 hrs and 20 hrs p.i and CFU were 
determined. The data obtained for each of the tissues sam-
pled 2 hrs p.i was compared statistically by using a two tail 
Student's t-test to the data obtained 6 hrs and 20 hrs p.i. * = 
p < 0.05, ** = p < 0.01 and *** = p < 0.005.
F. tularensis subsp. novicida and K. pneumoniae are found in  blood of infected mice at early time points Figure 7
F. tularensis subsp. novicida and K. pneumoniae are 
found in blood of infected mice at early time points. 
In order to determine the presence of F. tularensis subsp. 
novicida as well as K. pneumoniae in blood at early time points 
mice were infected with 2 × 104 CFU/20 μl and 2 × 109 CFU/
20 μl. Data correspond to the average of 4 mice per infec-
tious agent and dose and are given as Log CFU/200 μl. Mice 
were sacrificed 2 hrs, 6 hrs and 24 hrs pi, blood was plated 
and CFU were counted. The data obtained from mice 
infected with F. tularensis subsp. novicida at each time point 
and each bacterial dose was compared statistically by using a 
two tail Student's t-test to the data obtained from mice 
infected with K. pneumoniae. * = p < 0.05, ** = p < 0.01 and 
*** = p < 0.005.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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lung at this early time point (Fig. 1). Biodistribution data
obtained for 64Cu labeled F. tularensis subsp. novicida at
this time point correlates with the microPET data, show-
ing a substantial tropism for the liver followed by the
spleen that had a significantly higher %ID/g, than in the
case of the i.n. infection (p < 0.05) (Fig. 2). In addition,
statistical analysis showed that 20 hrs p.i, the lung, stom-
ach and cecum showed a significantly higher %ID/g fol-
lowing i.n infection but not i.p infection (p < 0.005, p <
0.05 and p < 0.05 respectively). When the i.v infection was
performed, we observed that 20 hrs p.i the majority of the
labeled organisms were present in the liver, spleen and GI
tract, seen by microPET image (Fig. 1). According to the
biodistribution data obtained 20 hrs p.i, the majority of
labeled  F. tularensis subsp.  novicida  was present in the
spleen and liver (Fig. 2), correlating with the microPET
images (Fig. 1). Furthermore, statistical analyses showed
that when comparing this infection route to the i.n route,
there is a significantly higher tropism of F. tularensis
subsp. novicida for spleen, liver and kidney (p < 0.05, p <
0.01 and p < 0.005 respectively) while there is a signifi-
cantly lower tropism for the nasal cavity, trachea, lung,
stomach and cecum (p < 0.05, p < 0.005, p < 0.005, p <
0.005 and p < 0.05 respectively) (Fig. 2).
Effect of bacterial strain
To test the potential effects of bacterial strains on dissem-
ination, two different bacterial strains, E. coli and K. pneu-
moniae, were labeled with 64Cu-PTSM and administered
i.n at the same dose of 2 × 109 CFU/20 μl used for F. tula-
rensis subsp. novicida. By both microPET analysis (Fig. 1)
and ex vivo isotope distribution at 20 h (Fig. 5), E. coli
exhibited the highest percentage of radioisotope in the
digestive tract and a barely detectable percentage in the
lung that was significantly lower than in the case of F. tula-
rensis subsp. novicida infected mice (p < 0.005) (Fig. 5). In
the case of K. pneumoniae infection (Fig. 1), another pul-
monary pathogen, a larger percentage of labeled bacteria
remained in the nasal cavity and less in the lung com-
pared with F. tularensis subsp. novicida at all time points
tested. Furthermore, our biodistribution data showed that
by 20 hrs p.i the %ID/g obtained in the lung for K. pneu-
moniae infected mice are significantly lower than for F.
tularensis  subsp. novicida  infected mice (p < 0.005). In
addition, spread of bacteria to the digestive tract appeared
to be somewhat delayed compared with F. tularensis
subsp. novicida. Interestingly, F. tularensis subsp. novicida
shows a significantly higher tropism for cecum when
compared to K. pneumoniae (p < 0.05) but not with E. coli
(Fig. 5). We also labeled LVS with 64Cu, infected mice by
the i.n route and imaged them by MicroPET (data not
shown). The results were similar to those obtained with
i.n inoculation of F. tularensis subsp.  novicida  showing
higher levels in the lung and GI tract. The biodistribution
data is shown in Fig. 5.
Isolation of Francisella tularensis subsp. novicida from 
gastrointestinal tract
Our microPET results show a persistent localization of F.
tularensis subsp. novicida in the GI tract. To test the pres-
ence of viable organisms in these tissues, we infected mice
i.n with a F. tularensis subsp. novicida Rif+ strain and deter-
mined the CFU in multiple tissues at 2 hrs, 6 hrs and 20
hrs p.i. We isolated F. tularensis subsp. novicida from lung,
stomach, large intestine, small intestine and cecum as
early as 2 hrs p.i (Fig. 6). The results obtained showed that
the number of organisms isolated from lung, stomach,
large intestine, small intestine and cecum increased 6 hrs
after infection although it was significant only for cecum
(p < 0.05). At 20 hrs after infection, the number of CFU
isolated from the stomach, large intestine and small intes-
tine showed a decrease, which was not statistically signif-
icant. However, the number of bacteria isolated from the
lung at 20 hrs was significantly increased (p < 0.005),
while for the cecum the CFU remained about the same
(Fig. 6).
Presence of Francisella in blood at a lower dose
As viable organisms were found in the blood by 24 hrs, it
was surmised that Francisella is capable of creating an
unusually rapid bacteremia. However, the microPET stud-
ies required a high dose of labeled organisms for image
detection. Therefore, it was important to determine if
mice receiving a lower dose would also exhibit viable
organisms in the blood. For this analysis, an i.n dose of 2
× 104 CFU/20 μl was given which is comparable to the
dose used in other published studies with Francisella [30].
The number of CFU/200 μl present in the blood of mice
infected with 2 × 104 CFU/20 μl of F. tularensis subsp. novi-
cida was compared with that of mice receiving the higher
dose used in the imaging studies (2 × 109 CFU/20 μl). Bac-
teria were found in blood of mice infected with the higher
bacterial dose as early as 2 hrs p.i and increased sequen-
tially at 6 hrs and 24 hrs (Fig. 7). In mice receiving the
lower dose, bacteria were detected as early as 24 hrs p.i
consistent with rapid entry into the bloodstream (Fig. 7).
The same experiments were performed with high and low
doses of K. pneumoniae. The results indicated that K. pneu-
moniae is also detectable in the blood at 24 hrs p.i at sig-
nificantly lower levels than F. tularensis subsp. novicida
when using the low infection dose (p < 0.005). On the
other hand, when comparing the presence of bacteria in
blood using a higher infection dose at 24 hrs p.i, K. pneu-
moniae was present at higher levels but this difference was
not statistically significant (Fig. 7).
Discussion
Several studies have been published to examine small ani-
mal infection models using in vivo bioluminescence
imaging (BLI) to track the course of infection or determine
the efficacy of anti-microbial therapies [31-49]. AsBMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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reviewed previously [35], there are many advantages to in
vivo imaging which include the ability to perform longi-
tudinal studies with the same animal, identifying novel
sites of infection such as the cecum [48] and gall bladder
[42], and increased information per animal allowing for
the use of fewer animals. One of the disadvantages of BLI
is the inability to accurately localize the focal point of bio-
luminescence within the living animal as biolumines-
cence produces only two dimensional data, and the
spatial resolution is limited [35]. In addition, the light is
significantly attenuated per cm of tissue and scattered by
fur and overlying tissues further complicating the data
generated [35]. The use of microPET overcomes these dis-
advantages providing high resolution data that are three
dimensional [16]. Thus, the entire depth of the body can
be measured and specific organs visualized, particularly
when combined with software that enables rotation of the
image, and X-ray computed tomography (CT) that reveals
the skeletal structure. Unfortunately, the CT capability
only became available at the very end of our experiments.
In addition, the high resolution of the microPET allows
for accurate determination of radioactivity within user
defined areas of interest. Using these measurements, both
the CFU and the % of input bacteria can be calculated
without sacrificing the animal and performing labor
intensive bacterial burden assays in order to track infec-
tion processes or assess therapeutic modalities. Moreover,
microPET is more easily transitioned to the clinic as com-
pared with BLI. The studies described herein used micro-
PET technology in addition to traditional labeling
techniques to assess the progressive spread of F. tularensis
subsp. novicida  during the initial hours of infection to
explore mechanisms associated with its extreme virulence
in mice.
When multiple mice were infected with radiolabeled F.
tularensis subsp. novicida by inhalation followed by imag-
ing, there was rapid widespread dissemination of organ-
isms from the upper respiratory tract to the lung despite
low inoculum volumes known to avoid direct introduc-
tion into the lung [50]. By 15 min, labeled organisms were
found in the lung and stomach with further spread
through the GI tract by 20 hrs. Similar results were
obtained with mice infected by the i.t route using two dif-
ferent protocols indicating that swallowing was unlikely
to be involved in the rapid dissemination to the GI tract.
By 20 hrs after pulmonary infection, radioactivity substan-
tially decreased in the upper respiratory tract. Activity in
the lung was maintained and in several animals, accumu-
lated to a greater degree suggesting an early tropism. This
was confirmed by the distribution of radioisotope post
necropsy where the highest levels of label were consist-
ently found in the lung at 20 hrs. Comparable results were
obtained when F. tularensis LVS was inoculated i.n. at the
same dose suggesting similar dissemination patterns in
Francisella. Similarly, bacterial burden assays have previ-
ously shown that mice intranasally infected with a low
bacterial dose of Francisella show a relatively high bacte-
rial burden in lung as early as 1 day post-infection [51,52].
Therefore, regardless of the inoculum dose, Francisella has
a high tropism for the lung when infected through the aer-
osol route.
Bacterial burden assays correlated with the imaging and
biodistribution data. A Rif+ strain with equivalent viru-
lence allowed assessment of viable bacteria in the GI tract.
The results obtained show that there is a wide dissemina-
tion of bacteria as early as 2 hrs after i.n. infection, and
CFU could be isolated from multiple organs including
lung, stomach, small intestine, cecum and large intestine.
It has been shown previously that Francisella can cause a
typhoid-like disease [9] and survive the harsh environ-
ment of the GI tract in mice [53]. However, the rapidity of
spread to the gut after i.n infection was unexpected. One
possible explanation of the rapid dissemination to the GI
tract in our model could involve a hematogenous and/or
lymphatogenous way through the Nasal Associated Lym-
phoid Tissue (NALT). It has been previously reported [54]
that the NALT is composed of mainly B cells, to a lesser
extent T cells and a small proportion of macrophages
(CD11b+ cells), and that the percentages of these cell types
observed in NALT are similar to the percentages observed
in spleen [54]. Since it is known that Francisella survives
and replicates inside macrophages, a possible way of dis-
semination from the nasal passages could be by macro-
phages present in the NALT acting as 'Trojan horses',
assuring the protection from the immune system and
facilitating a rapid dissemination to other tissues. This has
been observed for Salmonella typhimurium by trafficking
through T, B cells and macrophages [55,56].
One interesting aspect of working with microPET technol-
ogy is the possibility to identify novel sites of infection. In
our case, these experiments allowed us to identify the con-
centration of F. tularensis subsp. novicida in the cecum,
which has not been described previously. Several studies
using different organisms known to invade the gut includ-
ing Citrobacter rodentium, Helicobacter pylori and Burkholde-
ria cepacia appear to colonize the cecum [38,48,57]. In
addition, it has been previously reported that intranasally
delivered S. typhimurium in swine is present in cecum as
early as 3 hrs p.i [58]. The cecum, particularly the cecal
patch, contain lymphoid tissue that could play an impor-
tant role in immunity and possibly further bacterial dis-
semination. This aspect is currently under study in our
laboratory.
K. pneumoniae, another pulmonary pathogen, was used
for comparison as was a gut associated E. coli clinical iso-
late, and both were administered i.n. Interestingly, K.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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pneumoniae  in contrast to F. tularensis subsp.  novicida
exhibited little or no dissemination to the stomach during
the first two hours and was mainly confined to the nasal
cavity and trachea. Even at 20 hrs, the largest % of label
was still present in the nasal cavity although trafficking to
the GI tract was apparent by then. Interestingly, at these
early time points, the lung was not the major focus of
infection. In the case of E. coli, organisms at 20 hrs were
mainly confined to the GI tract. The results indicate dis-
tinct distribution patterns of pathogenic bacteria during
the first hours of infection when mice are given the same
number of organisms and by the identical route. Moreo-
ver, the early tropism to the lung in the case of Francisella
was dependent upon viable organisms as non-viable, bio-
synthetically  35S labeled bacteria failed to preferentially
traffic to the lung at 20 hrs compared to the viable
(unfixed) labeled bacteria. More of the non-viable organ-
isms appeared to traffic to the gall bladder as compared to
the viable labeled bacteria in this tissue at the same time
point. This suggests that the viable organisms begin colo-
nizing the lung rapidly.
Initially, we thought that the extreme rapidity of dissem-
ination was associated with the ability of Francisella to
enter the bloodstream quickly as CFU could be detected
in the blood at 20 hrs p.i. However, one of the disadvan-
tages of in vivo imaging in general is the requirement to
use large doses of organisms in order to visualize the
images. Therefore, we questioned if more physiological
doses of 103 or 104 organisms would result in a detecta-
ble bacteremia. And in fact, even at the lower doses, clear
evidence of viable bacteria were found by 20 hrs support-
ing this contention, and likely explaining the presence of
radioactivity in essentially all tissues analyzed by both
labeling techniques. However, we then tested K. pneumo-
niae for its ability to establish a bacteremia at these early
time points. Significantly, K. pneumoniae at both high
and low doses entered the blood stream, and if anything,
at increased levels with detection in some mice at earlier
time points. Despite this, K. pneumoniae infected mice
did not appear overtly ill whereas F. tularensis subsp.
novicida mice did as judged by pilo-erection, lethargy,
and hunched posture. Interestingly, K. pneumoniae main-
tained the bulk of the inoculum in the nasal cavity in
contrast to F. tularensis subsp. novicida, and it is possible
that this is an important site for entrance to the blood. In
fact, bacteremia has been reported in tularemia [10,59]
and the presence of F. tularensis LVS as well as SchuS4
strains in blood early after i.d infection has been
described [60]. Nonetheless, the extreme virulence of F.
tularensis subsp. novicida in mice may not be attributed
solely to blood vasculature ingress.
Francisella tularensis is a bacterium that can adapt to many
different environments including soil, ground water, and
growth in amoeba [11]. It also replicates intracellularly
within humans and a variety of other species causing sig-
nificant morbidity and mortality. It contains a number of
genes that facilitate survival under a variety of conditions
[61]. Correlative to this, Francisella is known to cause
infection in humans by inhalation, ingestion, eye contact,
insect bites, and cuts in the skin [3,9]. Interestingly, the
pulmonary route causes the most severe infections with
substantial mortality, although other routes of infection
have been known to develop into severe infections but
with less frequency [9]. Therefore, other routes of infec-
tion were tested using the same number of bacteria. With
oral infection (i.g), the majority of radiolabeled Fran-
cisella trafficked and remained in the GI tract through 20
hrs p.i. After an i.d injection during this same time period,
most of the organisms remained in the skin and muscle
tissue. Both oral and i.d (cuts in skin) routes cause illness,
but usually less severe in patients, and it is possible that
this alteration in trafficking is involved in the decreased
severity. Mice were also infected by the i.p and i.v routes.
In both cases, the majority of the bacteria were localized
to the liver and spleen and to a lesser extent to the GI tract
and the lung. Comparing the biodistribution data
obtained at 20 hrs p.i among all of the infection routes,
the results suggest that the numbers of F. tularensis subsp.
novicida bacteria present in mice after i.n and i.t infection
are higher in the lung than in mice infected through any
of the other infection routes tested despite the same infec-
tion doses. Several studies have used LVS to examine var-
ious routes of inoculation, mostly at later time points of
infection to study colonization [53,62,63]. However,
KuoLee et al. [53], reported CFU in lung and GI tract at 1
day p.i following a dose of 108 CFU of LVS, consistent
with our findings. In addition, Woolard et al. [63] used an
i.d dose of 105 CFU of LVS and showed barely detectable
CFU in the lung and spleen at 1 day consistent with our
radiodistribution data at 20 hrs p.i. We speculate that the
different trafficking patterns are due, in fact by differences
in the innate immune response mounted depending on
the initial tissue impacted as suggested by recent studies of
organ specific immunity [64-69]. We and others have
found evidence of a delay in the innate immune response
following i.n infection, indicated by the absence of pro-
inflammatory cytokines and chemokines early after infec-
tion (6 hrs p.i – 48 hrs p.i) and beginning to increase only
after 72 hrs p.i [70,71]. We propose that the acute viru-
lence associated with inhaled Francisella is its extremely
rapid colonization of the lung leading to pulmonary fail-
ure and eventual multiple organ failure before an effective
immune response can be elicited. To test this, future stud-
ies will use microPET with CT capabilities together with
radiolabeled antibodies to both bacteria and distinct
immune cell subsets so that continued dissemination,
increases in bacterial biomass, and the disease process can
be evaluated at later time points.BMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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Conclusion
By using various labeling techniques, imaging, and bacte-
rial counting, we conclude that Francisella rapidly dissem-
inates within hours to multiple tissues regardless of the
route of infection with the possible exception of the intra-
dermal route. However, the route of infection alters the
trafficking patterns. In the case of the pulmonary route,
which is the most dangerous, the bacteria rapidly traffic to
the lung and throughout the GI tract but by 20 hrs appears
to preferentially colonize the lung indicating an early tro-
pism to this organ. We speculate that the mode of trans-
mission alters the severity of the disease because of
documented differences in organ specific immunity.
Methods
Bacterial strains and culture media
Francisella tularensis subsp.  novicida  strain U112 was
obtained from Dr. Bernard Arulanandam (UTSA) through
Dr. Fran Nano (University of Victoria). It was grown in
Tripticase Soy Agar/Broth (Becton Dickinson), supple-
mented with 0.1% cysteine (TSAcys). Escherichia coli (clin-
ical isolate) was obtained from Dr. Stephen Mattingly
(UTHSCSA) and was grown in Luria Bertani Agar (LB
medium).  Klebsiella pneumoniae (ATCC # 43816) was
obtained from Dr. Peter Dube (UTHSCSA) and was grown
in LB. Bacteria were resuspended in broth and then taken
to a titer of 2 × 109 colony forming units (CFU)/300 μl.
Radiolabeling of bacteria with [64Cu] PTSM
Resuspended bacteria were added to 400 μCi [64Cu] PTSM
and incubated in a water bath at 42°C for 1 hr. [64Cu] was
conjugated to PTSM as previously described [72]. Radiola-
beled bacteria were centrifuged at 15000 g for 4 min.
Supernatants were removed, and both pellets and super-
natants were measured for radioactivity to determine radi-
olabeling efficiency of the bacteria. Preliminary
radiolabeling studies were performed using different bac-
terial doses ranging from 103 to 109 CFU/300 μl. It was
determined that the concentration of 109/300 μl was most
efficiently labeled and that doses of 109 labeled organisms
were required for visualization by microPET. In addition,
control experiments were performed to determine the
effect of labeling on viability of the bacteria with time. It
was found that there was no change in the viability of the
organisms after 90 min of labeling indicating a lack of tox-
icity associated with the labeling method. In addition, the
potential leakage of label was determined by incubating
labeled and washed organisms for extended periods. After
incubation, bacteria were washed again, and the amount
of label in the supernatant and pellets determined at 24
hrs. 79.5 +/- 2.1% of the label remained in the pellet indi-
cating the stability of the labeling process. In addition,
bacteria viability post-labeling was checked at 90 min, 24
hrs and 48 hrs post-infection and was found to be
114.5%, 43.8% and 57.4% respectively. Labeled organ-
isms were resuspended in sterile 1× phosphate-buffered
saline (PBS) for inoculation of mice.
In vivo bacterial biodistribution
Labeled bacteria pellets were resuspended in 30 μl or 50
μl of sterile 1× PBS to a final concentration of 2 × 109 CFU/
20–25 μl intranasally (i.n) or 2 × 109 CFU/50 μl intrader-
mal (i.d). C57BL/6 females 6–8 wk old were anesthetized
with vaporized isofluorane for the initial experiments and
later by intramuscular injection of 100 μl of ketamine-
xylazine mixture containing (30 mg/mL ketamine, 4 mg/
mL xylazine in 1× PBS). No apparent differences in images
were observed between the two methods of anesthesia.
Mice were then i.n inoculated with 10–12.5 μl of bacterial
suspension in each nostril drop by drop thus allowing the
mice to slowly inhale the inoculum. Intradermal inocula-
tions were done by injecting 50 μl of 2 × 109 CFU in the
right leg of mice. A total of fifteen mice were inoculated
i.n, nine with F. tularensis subsp. novicida, three more with
E. coli and three with K. penumoniae. Additional routes of
inoculation included intratracheal (i.t), intragastric (i.g),
intraperitoneal (i.p) and intravenous (i.v) inoculations of
64Cu labeled F. tularensis subsp. novicida using 2 × 109
CFU/50 μl for the i.t and i.v infections and 2 × 109 CFU/
100 μl for the i.g and i.p infections; three mice were inoc-
ulated with F. tularensis subsp. novicida for each of the
routes. The i.t infection was performed according to the
procedure of Rubins et al. (40). Briefly, mice were anes-
thetized with vaporized isofluorane, suspended in an
upright position, and the tongue was extended outwards
and towards the side of the mouth with forceps. The inoc-
ulum was then delivered by pipette to the back of the
throat while covering the nose. This procedure has been
shown to prevent swallowing with the vast majority of the
inoculum delivered to the trachea and lungs [28,29]. The
i.g infection was performed by using a gavage needle to
directly deliver the inoculum into the stomach, while the
intraperitoneal infection was accomplished by injecting
100 μl of the inoculum with a 23-gauge needle directly in
the right bottom quadrant of the peritoneum. Finally, the
intravenous infection was achieved by injecting 50 μl of
the inoculum in the mice tail vein with a 28-gauge needle.
All animals were imaged for 15–20 min, immediately
after infection (labeled 0.25 hr) and at 2 and 20 hrs by
using a microPET-R4 rodent scanner (Concorde Microsys-
tems, Knoxville, TN, USA). MicroPET provides a 10 cm by
8 cm field of view with a reconstructed resolution of 2.25
mm in the central 40 mm of the field of view. Images are
reconstructed using Fourier re-binning followed by two-
dimensional filtered backprojection. Towards the end of
our studies, a FLEX Pre-Clinical Platform (Gamma-Med-
ica-Ideas, Northridge, CA) was acquired; this allowed the
acquisition of an X-ray computed tomography (CT) imageBMC Microbiology 2008, 8:215 http://www.biomedcentral.com/1471-2180/8/215
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permitting the visualization of the skeletal structure of the
mice being analyzed. The FLEX pre-Clinical Platform CT
device provides an 8.7 cm field of view, fly acquisition, 2
× 2 binning, and 256 projections, with a spatial resolution
of ~100 μm. This procedure was performed for 1 min
prior to acquire the microPET image. We made use of this
device to image mice that had been previously infected
with 64Cu labeled F. tularensis subsp. novicida by the i.n,
i.p and i.v routes of infection.
Once the mice had been scanned for the last time point,
they were sacrificed and various tissues (as shown in Fig 2)
were harvested in order to quantify the amount of 64Cu
still present in them by using an automatic well-type
gamma counter (γ 8000 Beckman Coulter Fullerton, CA).
Finally, some of the tissues harvested from F. tularensis
subsp. novicida infected animals were weighed, homoge-
nized in 1× PBS, serially diluted, and plated on TSAcys
(Becton Dickinson) to determine CFU/g of tissue in the
i.n infected mice. All the experimental procedures were in
compliance with federal guidelines and the institutional
animal care and use committee.
Isolation of rifampicin resistant Francisella tularensis 
subsp. novicida from the gastrointestinal (GI) tract
In order to test for CFU in the GI tract, several rifampicin
resistant F. tularensis subsp. novicida (F. tularensis subsp.
novicida Rif+) isolates were generated and tested for viru-
lence. F. tularensis subsp. novicida was grown in a liquid
culture in tripticase soy broth (TSB) supplemented with
0.1% L-cysteine with agitation at 37°C overnight (ON).
1 mL of culture was then centrifuged at 13,000 rpm for 4
min; the cell pellet was resuspended in 100 μl of 1× ster-
ile PBS and plated on TSAcys plates containing 200 μg/
mL rifampicin. Rif+ bacteria were streaked again on TSA-
cys plates containing 200 μg/mL rifampicin. Colonies
that grew better were then streaked again on TSAcys
plates containing 30 μg/mL rifampicin. A Rif+ isolate that
was shown to have equivalent virulence to the wt strain
(LD50 10) was then used in subsequent studies. For anal-
yses of the GI tract, nine C57BL/6 females 6–8 wk old
were anesthetized and i.n inoculated with 2 × 109 CFU/
20 μl of F. tularensis subsp. novicida Rif+ bacterial suspen-
sion. At serial time points, mice were sacrificed after
anesthesia using a mixture of ketamine-xylazine. Lung,
stomach, large intestine, small intestine and cecum were
collected and organs homogenized; serial dilutions were
made and plated on TSAcys plates containing 30 μg/mL
rifampicin.
Metabolic labeling of bacteria with 35S
F. tularensis subsp. novicida cultures (50 mL) were incu-
bated at 37°C for 2 hrs with agitation. Bacterial cultures
were then centrifuged, supernatants were removed and
cell pellets were washed twice with either TSB or LB liquid
medium. Bacteria were re-suspended in 50 mL DMEM
medium without L-glutamine, L-methionine and L-
cysteine (MP Biomedicals) and incubated at 37°C for 15
min with agitation. Subsequently, 230 μCi of 35S were
added to each bacterial culture and incubated for an addi-
tional 2 hrs. Bacterial cultures were then concentrated and
the amount of 35S present in the cell pellets and superna-
tants were measured to determine efficiency of labeling.
Once the bacteria were labeled, serial dilutions were pre-
pared and plated on TSAcys to determine CFU.
Biodistribution of labeled bacteria with 35S
Labeled bacterial pellets were resuspended in 1× PBS to a
final concentration of 2 × 109 CFU. Mice (C57BL/6 6–8
wk old) were anesthetized and inoculated i.n with 20–25
μl of the bacterial suspension and inoculated i.t with 50 μl
of inoculum. In order to infect mice by the i.t route an
endotracheal intubation was performed by using a BioLite
small animal intubation system (BioTex, Inc., TX). Briefly,
mice were anesthetized by intramuscular injection of ket-
amine-xylazine as previously described. Subsequently
mice were suspended from the incisor wire on the intuba-
tion stand, followed by the tracheal intubation with a flex-
ible intravenous catheter over a fiber-optic laser attached
to an illuminator that allows a better visualization of the
oralpharyngeal cavity. Once inside the trachea, the
fiberoptic was drawn out and a 1 mL syringe was plugged
to the catheter, and the inculum was delivered to the
mouse. This method of inoculation allowed us to avoid
any accidental swallowing of the inoculum.
After infection, mice were sacrificed at 20 hrs p.i in the
case of i.n infected mice and at 1–2 hrs and 20 hrs post-
inoculation in the case of i.t infected mice, various tissues
were removed, and the amount of 35S in each tissue was
determined by using a multi-purpose scintillation counter
(LS6500 Beckman Coulter Fullerton, CA). In addition,
several tissues were weighed, homogenized in 1× PBS,
serially diluted, and plated to determine CFU/g of tissue
in the case of the i.n infected mice.
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